When we performed the multivariate analysis, only recipient age and DGF were clinical factors significantly associated with increased risk of CMV infection; and for immunotherapy, only the protective effect of imTOR was close to significance ( Table 4 ).
← all excerpts
The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation.
1
—
—